• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

[治疗性寡核苷酸:综述]

[Therapeutic oligonucleotides: a review].

作者信息

Wang Xiaolong, Xian Jingnü, Chen Gang, Peng Haibo

机构信息

Department of Biotechnology, College of Marine Life Sciences, Ocean University of China, Qingdao 266003, Shandong, China.

出版信息

Sheng Wu Gong Cheng Xue Bao. 2018 May 25;34(5):664-675. doi: 10.13345/j.cjb.170401.

DOI:10.13345/j.cjb.170401
PMID:29893074
Abstract

Oligonucleotides are widely used as effective tools to regulate gene expression and drugs for targeted gene therapy. Therefore, they are potentially useful for the treatment of viral, tumor and hereditary diseases. Therapeutic oligonucleotides include antisense oligonucleotide, small interference RNA (siRNA), Ribozyme, DNAzyme, anti-gene, CpG, decoy and aptamer. Therapeutic oligonucleotides usually carry certain modifications, such as phosphorothioates, fluoro or locked nucleic acids, to enhance the stability and specificity, and reduce the side-effects, because natural oligonucleotides have poor stability in vivo, low specificity and side effects. Now oligonucleotides are usually manufactured by chemical synthesis, with low purity and high cost. Here, we review a novel thermocyclic reaction for the amplification of oligonucleotides, referred to as Polymerase-endonuclease Amplification Reaction (PEAR) catalyzed by two thermostable enzymes. PEAR is simple, efficient, and stable. Comparing with traditional chemical synthesis, PEAR-based enzymatic production of oligonucleotides could be a robust alternative method for the large-scale production of therapeutic or non-therapeutic oligonucleotides.

摘要

寡核苷酸作为调节基因表达的有效工具和靶向基因治疗的药物被广泛应用。因此,它们在治疗病毒、肿瘤和遗传性疾病方面具有潜在用途。治疗性寡核苷酸包括反义寡核苷酸、小干扰RNA(siRNA)、核酶、脱氧核酶、反基因、CpG、诱饵和适体。治疗性寡核苷酸通常带有某些修饰,如硫代磷酸酯、氟或锁核酸,以提高稳定性和特异性,并减少副作用,因为天然寡核苷酸在体内稳定性差、特异性低且有副作用。目前寡核苷酸通常通过化学合成制备,纯度低且成本高。在此,我们综述了一种用于寡核苷酸扩增的新型热循环反应,称为由两种耐热酶催化的聚合酶-核酸内切酶扩增反应(PEAR)。PEAR简单、高效且稳定。与传统化学合成相比,基于PEAR的寡核苷酸酶促生产可能是大规模生产治疗性或非治疗性寡核苷酸的一种强大替代方法。

相似文献

1
[Therapeutic oligonucleotides: a review].[治疗性寡核苷酸:综述]
Sheng Wu Gong Cheng Xue Bao. 2018 May 25;34(5):664-675. doi: 10.13345/j.cjb.170401.
2
Therapeutic oligonucleotides.治疗性寡核苷酸。
Methods Mol Biol. 2011;764:1-15. doi: 10.1007/978-1-61779-188-8_1.
3
Polymerase-endonuclease amplification reaction (PEAR) for large-scale enzymatic production of antisense oligonucleotides.聚合酶内切酶扩增反应(PEAR)用于大规模酶促生产反义寡核苷酸。
PLoS One. 2010 Jan 1;5(1):e8430. doi: 10.1371/journal.pone.0008430.
4
Preparation of 5'-O-(1-Thiotriphosphate)-modified oligonucleotides using polymerase-endonuclease amplification reaction (PEAR).使用聚合酶内切酶扩增反应 (PEAR) 制备 5'-O-(1-硫代三磷酸)-修饰的寡核苷酸。
PLoS One. 2013 Jul 4;8(7):e67558. doi: 10.1371/journal.pone.0067558. Print 2013.
5
Re-Engineering RNA Molecules into Therapeutic Agents.将 RNA 分子重建成治疗剂。
Acc Chem Res. 2019 Apr 16;52(4):1036-1047. doi: 10.1021/acs.accounts.8b00650. Epub 2019 Mar 26.
6
Sugar boost: when ribose modifications improve oligonucleotide performance.糖基增强:核糖修饰如何提升寡核苷酸性能
Curr Opin Mol Ther. 2008 Apr;10(2):168-75.
7
Liver as a target for oligonucleotide therapeutics.肝脏作为寡核苷酸治疗药物的靶标。
J Hepatol. 2013 Dec;59(6):1354-9. doi: 10.1016/j.jhep.2013.05.045. Epub 2013 Jun 12.
8
Locked nucleic acids: promising nucleic acid analogs for therapeutic applications.锁核酸:有前途的治疗应用核酸类似物。
Chem Biodivers. 2010 Mar;7(3):536-42. doi: 10.1002/cbdv.200900343.
9
Prospects for nucleic acid-based therapeutics against hepatitis C virus.针对丙型肝炎病毒的核酸类药物治疗的前景。
World J Gastroenterol. 2013 Dec 21;19(47):8949-62. doi: 10.3748/wjg.v19.i47.8949.
10
A status update of modified oligonucleotides for chemotherapeutics applications.用于化疗应用的修饰寡核苷酸的现状更新。
Curr Protoc Nucleic Acid Chem. 2011 Sep;Chapter 4:Unit 4.1.1-22. doi: 10.1002/0471142700.nc0401s46.

引用本文的文献

1
Direct dsRNA preparation by promoter-free RCT and RNase H cleavage using one circular dsDNA template with a mismatched bubble.使用带有错配泡的单个环状双链 DNA 模板通过无启动子 RCT 和 RNase H 切割制备直接 dsRNA。
RNA. 2023 Nov;29(11):1691-1702. doi: 10.1261/rna.079670.123. Epub 2023 Aug 3.